Cases started on MDR-TB treatment in Lower-middle income (World Bank)
Lower-middle income (World Bank): Cases started on MDR-TB treatment was 83,518 in 2024. ◆ Volatile
Latest (2024)
83,518
Change on year
down 8.7%
Rank
2nd
of 11 groups
All-time high
95,088
in 2022
All-time low
0
in 2005
Years of data
20
2005–2024
Cases started on MDR-TB treatment in Lower-middle income (World Bank), 2005–2024
Source: World Health Organization, Global Health Observatory.
Analysis
In 2024, cases started on mdr-tb treatment in Lower-middle income (World Bank) stood at 83,518.
That represents a change of down 8.7% on the previous year and up 91.2% over ten years.
Over the whole period, cases started on mdr-tb treatment in Lower-middle income (World Bank) peaked at 95,088 in 2022 and was at its lowest, 0, in 2005.
The series is highly variable year to year, so single readings are best treated with caution.
Cases started on MDR-TB treatment in Lower-middle income (World Bank), year by year
| Year | Value | Change |
|---|---|---|
| 2005 | 0 | — |
| 2006 | 0 | — |
| 2007 | 0 | — |
| 2008 | 1,498 | — |
| 2009 | 5,208 | +247.7% |
| 2010 | 6,937 | +33.2% |
| 2011 | 10,677 | +53.9% |
| 2012 | 24,297 | +127.6% |
| 2013 | 34,683 | +42.7% |
| 2014 | 43,672 | +25.9% |
| 2015 | 47,569 | +8.9% |
| 2016 | 56,542 | +18.9% |
| 2017 | 61,829 | +9.4% |
| 2018 | 75,311 | +21.8% |
| 2019 | 90,406 | +20.0% |
| 2020 | 67,722 | -25.1% |
| 2021 | 79,690 | +17.7% |
| 2022 | 95,088 | +19.3% |
| 2023 | 91,487 | -3.8% |
| 2024 | 83,518 | -8.7% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 1,341 | 0 | 5,208 | 5 |
| 2010s | 45,192 | 6,937 | 90,406 | 10 |
| 2020s | 83,501 | 67,722 | 95,088 | 5 |
Countries ranked near Lower-middle income (World Bank)
- 1 India 51,765 compare
- 2 Russian Federation 23,722 compare
- 3 China 13,984 compare
- 4 Indonesia 9,421 compare
- 5 Philippines 6,631 compare
More health data for Lower-middle income (World Bank)
- Pertussis - number of reported cases 7,080 (2025)
- Diphtheria - number of reported cases 20,601 (2025)
- Measles - number of reported cases 97,321 (2025)
- Total tetanus - number of reported cases 16,092 (2025)
- Neonatal tetanus - number of reported cases 838 (2025)
- Infant mortality rate (probability of dying between birth and age 1) 33.08 (2024)
- Number of neonatal deaths 1.39 million (2024)
- Thinness among children and adolescents, BMI-for-age < -2 standard 13.5% (2024)
- Under-five mortality rate 43.8 (2024)
- Neonatal mortality rate 21.61 (2024)
Frequently asked questions
- What is cases started on mdr-tb treatment in Lower-middle income (World Bank)?
- Cases started on mdr-tb treatment in Lower-middle income (World Bank) was 83,518 in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest cases started on mdr-tb treatment recorded in Lower-middle income (World Bank)?
- The highest recorded value was 95,088 in 2022.
- What is the lowest cases started on mdr-tb treatment recorded in Lower-middle income (World Bank)?
- The lowest recorded value was 0 in 2005.
- How does Lower-middle income (World Bank) rank for cases started on mdr-tb treatment?
- Lower-middle income (World Bank) ranks 2nd out of 11 groups with data for 2024.
- Is cases started on mdr-tb treatment rising or falling in Lower-middle income (World Bank)?
- Over the last ten years it is up 91.2%. The long-run trend across the full record is volatile.
- Where does this Lower-middle income (World Bank) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Cases started on MDR-TB treatment. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 20 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).